i.v. administration of allogenic MSC - whether BM-MSC or AD-MSC, in pMCAO infarct was associated with good functional recovery, and reductions in cell death as well as increases in cellular proliferation, neurogenesis, oligodendrogenesis, synaptogenesis and angiogenesis markers at 14 days post-infarct.
No takes yet. Share an insight, caveat, or question.
Gutiérrez‐Fernández et al. (2013) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: